EDGEWELL PERSONAL CARE Co (EPC) stock
EPCNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 13, 2026Score 7/3021% above fair value
$28.25+0.28 (+1.00%)
Close on Nov 18, 2026Market cap $1.30BP/E –Yield –
Edgewell Personal Care operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Edgewell Personal Care's operating income for the twelve months ending Jun 30, 2026 was $17.90M, down 85.5% year over year. For fiscal 2025 it was $96.60M, down 51.5% from the year before. The highest annual figure on record is $243.80M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $96.60M | -51.5% |
| FY2024 | Sep 30, 2024 | $199.30M | -12.2% |
| FY2023 | Sep 30, 2023 | $227.00M | +24.5% |
| FY2022 | Sep 30, 2022 | $182.30M | -24.0% |
| FY2021 | Sep 30, 2021 | $239.90M | +36.3% |
| FY2020 | Sep 30, 2020 | $176.00M | -27.8% |
| FY2019 | Sep 30, 2019 | $243.80M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $25.00M | -44.4% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $18.40M | -62.4% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$18.90M | -303.2% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$6.60M | -132.4% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $45.00M | -45.6% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $49.00M | -30.1% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $9.30M | -64.4% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $20.40M | -60.8% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $82.70M | -4.1% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $70.10M | +23.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $26.10M | -18.2% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $52.10M | -11.5% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $86.20M | +72.7% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $56.80M | +36.2% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $31.90M | +0.3% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $58.90M | -8.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $49.90M | -29.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $41.70M | -33.7% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $31.80M | -23.6% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $64.30M | +55.7% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $71.10M | +63.4% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $62.90M | +16.3% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $41.60M | +12.1% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $41.30M | -61.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $43.50M | -62.7% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $54.10M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $37.10M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $106.70M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $116.50M | – |
See a number that looks wrong?